Tag John Plastaras

Introduction Hematologic malignancies arising from bone marrow cell populations classically include leukemias, either of lymphocytic or myelogenous origin, and multiple myeloma (MM), of plasma cell origin. The mainstay of definitive therapy for these malignancies is high-dose chemotherapy with local therapy,…

Introduction Radiotherapeutic palliation of lymphoma is unique among cancers for several reasons. First, unlike most cancers, even patients with disseminated “stage IV” disease can be routinely cured or put into a lasting remission with systemic therapies alone. Even in the…